The Valley Desk

NCT03393520 · Interventional trial

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Overall registry status Completed

Phase 3

Conditions Agitation in Patients With Dementia of the Alzheimer's Type

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov